Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Translational therapy in patients with Osteogenesis imperfecta – pilot trial of denosumab
2012-002887-29Phase 2Completed
- Sponsor
- University of Cologne
- Start
- Nov 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in osteogenesis imperfecta (OI), sponsored by University of Cologne. Started Nov 2012; status: completed.
02
Drugs
denosumab
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on 2012-002887-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002887-29.